Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Technology

Technology

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Ars Technica

TechnologyArs Technica·Aug 19, 2026·1 min read

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to target a patient's unique cancer mutations—was effective in a late-stage clinical trial of patients with…

View original source — Ars Technica ↗

ShareShare on X Share on Facebook

Related stories

A British AI-chip startup is raising at $6.5bn after an Anthropic deal

TechnologyAug 19, 2026 · 1 min

A British AI-chip startup is raising at $6.5bn after an Anthropic deal

AI was supposed to win people over by now — it hasn’t

TechnologyAug 19, 2026 · 1 min

AI was supposed to win people over by now — it hasn’t

Coders are slacking when it comes to web standards — and that simply won't do in the AI age

TechnologyAug 19, 2026 · 1 min

Coders are slacking when it comes to web standards — and that simply won't do in the AI age

TechnologyAug 19, 2026 · 1 min

Google packs Search and Gemini with new AI study tools